Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03092895
What this trial is testing

SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Who this might be right for
Advanced Primary Liver CancerAdvanced Biliary Tract Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 157
Testing effectiveness (Phase 2)UnknownNCT03912857
What this trial is testing

Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Study completedNCT06238752
What this trial is testing

First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC

Who this might be right for
Advanced Gastric Adenocarcinoma
Renmin Hospital of Wuhan University 33
Testing effectiveness (Phase 2)UnknownNCT04415385
What this trial is testing

The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Zhejiang Cancer Hospital 48
Large-scale testing (Phase 3)Looking for participantsNCT04342910
What this trial is testing

Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC

Who this might be right for
Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd. 550
Not applicableLooking for participantsNCT05409482
What this trial is testing

A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Meng Chao Hepatobiliary Hospital of Fujian Medical University 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05759572
What this trial is testing

Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Fudan University 145
Testing effectiveness (Phase 2)UnknownNCT03811054
What this trial is testing

The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Beijing Chest Hospital 60
Testing effectiveness (Phase 2)UnknownNCT04659785
What this trial is testing

Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Tianjin Medical University Second Hospital 53
Large-scale testing (Phase 3)UnknownNCT02824458
What this trial is testing

Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations

Who this might be right for
EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors
Sun Yat-sen University 246
Testing effectiveness (Phase 2)UnknownNCT04850040
What this trial is testing

A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and Oxaliplatin

Who this might be right for
Hepatocellular Carcinoma Resectable
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 15
Testing effectiveness (Phase 2)UnknownNCT04133337
What this trial is testing

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Who this might be right for
Lung DiseasesNeoplasmsRespiratory Tract Diseases+2 more
Sichuan Cancer Hospital and Research Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT07033819
What this trial is testing

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

Who this might be right for
Ovarian Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 48
Testing effectiveness (Phase 2)Study completedNCT03878472
What this trial is testing

Neoadjuvant Immunotherapy for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Qilu Hospital of Shandong University 25
Testing effectiveness (Phase 2)UnknownNCT04303741
What this trial is testing

A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46
Testing effectiveness (Phase 2)Looking for participantsNCT06607107
What this trial is testing

MFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 29
Testing effectiveness (Phase 2)Study completedNCT03417895
What this trial is testing

SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy

Who this might be right for
Small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 59
Testing effectiveness (Phase 2)UnknownNCT05290116
What this trial is testing

HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Yunfei Yuan 17
Testing effectiveness (Phase 2)Study completedNCT05027386
What this trial is testing

Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.

Who this might be right for
Neuroblastoma
Sun Yat-sen University 125
Testing effectiveness (Phase 2)Study completedNCT03083041
What this trial is testing

SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jiangsu HengRui Medicine Co., Ltd. 210
Next Page